Nestlé unveils science-backed protein drinks to help manage hunger, support muscle health and aid weight loss for GLP-1 users ...

During the time period 2020 to 2023, approximately 1 in 5 youth and 1 in 3 adults with type 1 diabetes and severe obesity ...

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...

While medications like Ozempic and Wegovy are delivering positive weight loss outcomes, many consumers only use them for a relatively short period, giving better-for-you brands and retailers an ...

Insurance companies face a growing challenge as they adapt to the rise of GLP-1 receptor agonists, such as Ozempic and Wegovy ...

Nestle SA is launching GLP-1-friendly beverages under its Boost brand that contain a proprietary whey protein microgel technology, according to the company. Nestle said the innovation allows for more ...

Medications like Ozempic, Wegovy, and Zepbound have helped many Americans lose weight, but there are still some misconceptions about these medications and metabolic health. Centre Spring MD founder ...

Millions of dollars in a new $32.6 billion state budget proposal could allow for the return of GLP-1 coverage for some state employees.

Millions of dollars in a new state budget proposal could allow for the return of GLP-1 coverage for some state employees.

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 ...

Accessory company Fossil Group, which selected Assembly as its global integrated media agency in May 2024, saw an 8% increase ...